Ilasave 10mg Tablet contains Ilaprazole, a proton pump inhibitor (PPI) indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, and other acid-related disorders. Ilaprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing gastric acid secretion. This reduction in acid production promotes healing of acid-induced mucosal damage and provides symptomatic relief from heartburn, acid regurgitation, and epigastric discomfort. Ilasave 10mg is typically administered orally once daily, preferably before meals, with dosage adjustments based on clinical response and severity of the condition. It is well tolerated, with a safety profile comparable to other PPIs, although potential adverse effects may include headache, diarrhea, abdominal pain, and nausea. Caution is advised in patients with hepatic impairment or those on concomitant medications metabolized via the cytochrome P450 system due to possible drug interactions. Long-term use should be monitored to avoid potential risks such as vitamin B12 deficiency, hypomagnesemia, and increased susceptibility to gastrointestinal infections. Ilasave 10mg Tablet should be used under medical supervision, ensuring appropriate diagnosis and monitoring for optimal therapeutic outcomes.